RAYNHAM, Mass., Jan. 25, 2017 /PRNewswire/ — DePuy Synthes Companies today announced an exclusive agreement in the U.S. between DePuy Synthes Sales, Inc. and Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) to co-promote EXPAREL®, a long-lasting, non-opioid, local analgesic administered at the orthopaedic surgical site. The agreement allows DePuy Synthes to promote EXPAREL […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone